§ BIOTECHNOLOGY
USD · BiotechnologyVIR
VIR BIOTECHNOLOGY INC
USDSector · BiotechnologyBeta · 1.66
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
129 increased/new, 80 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 1.10 | EPS (TTM) | -3.16 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 18.0M | 0.0% | +10% |
| ARCH Venture Management, LLC | 12.9M | 17.1% | ±0% |
| SB INVESTMENT ADVISERS (UK) LTD | 10.9M | 1.3% | −17% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9.2M | n/a | n/a |
| GSK plc | 8.6M | 12.8% | ±0% |
| State Street | 7.1M | 0.0% | +15% |
◇ AC INTELLIGENCE
Top institutional owners for VIR as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER89.9% · 0 holders
OTHER6.0% · 174 holders
PASSIVE / INDEX1.6% · 9 holders
DEALER / BANK1.4% · 25 holders
QUALITY / COMPOUNDER0.6% · 18 holders
TACTICAL / MACRO0.3% · 4 holders
INCOME / DEFENSIVE0.2% · 21 holders
SYSTEMATIC / QUANT0.1% · 4 holders
ACTIVIST0.1% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for VIR in the last 180 days.